COLTENE Holding (CLTN) Fair Value & Analysis
Healthcare · CH · Market cap CHF 307M
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 6 days ago
Share price −0.2% over the past month.
Price vs Fair Value (12 months)
12‑month range CHF 42.77 – CHF 68.33 · fair‑value band CHF 25.95 – CHF 53.70 · the CHF 51.20 price screens above the CHF 38.22 fair value. As of Jun 24, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
COLTENE Holding (CLTN) currently trades at CHF 51.20, while our model-based Fair Value estimate is CHF 38.22 — implying the stock looks roughly 25.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, COLTENE Holding generated revenue of CHF 240M at a net margin of 6.2%. Revenue declined 0.5% year over year. It earns a return on equity of 14.3%. Net debt stands at CHF 26.3M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. The company offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, characterizations, and parapulpal pins; and endodontics products, such as cold sprays, hand files, shaping and retreatment files, endo motors, rinsing and disinfection system, drying, temporary fillings, sealers, guttapercha points, and posts and drills. It also provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consist of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams, dental dam clamps and accessories, dental scalers, electrosurgery, and occlusion verificatio…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
COLTENE Holding reported revenue of CHF 240M in FY2025 versus CHF 279M in FY2021, a compound −3.7%/yr. Reported net income was CHF 14.9M in FY2025, compounding −17.1%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.95 | $182.39 | -55% |
| EssilorLuxottica Société anonyme ESLOF | $205.86 | $114.90 | -44% |
| HOYA Corporation HOCPY | $162.33 | $101.00 | -38% |
| Medline Inc MDLN | $33.61 | $31.78 | -5% |
| Becton, Dickinson and Company BDX | $147.79 | $124.26 | -16% |
| Alcon Inc ALC | $66.11 | $36.99 | -44% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is COLTENE Holding (CLTN) undervalued?
What is the fair value of CLTN?
What is the quality score of CLTN?
What is the revenue of COLTENE Holding (CLTN)?
What is the net profit margin of CLTN?
Does COLTENE Holding pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.